Lenalidomide derivatives and proteolysis-targeting chimeras for controlling neosubstrate degradation

Satoshi Yamanaka(CellFree Sciences (Japan)), Tatsuya Sawasaki(CellFree Sciences (Japan))
Nature Communications
August 18, 2023
Cited by 58


Related Papers